Intra-carotid arterial transfusion of autologous circulatory derived CD34+ cells for old ischemic stroke patients - a phase I clinical trial to evaluate safety and tolerability

This phase I clinical trial tested the hypothesis that circulatory CD34+ cell therapy might be safe for old ischemic stroke (IS) (defined as IS>6 months) patients and also to evaluate the neurological function after the therapy. Nine old IS patients (with mean IS interval: 8.6 ± 6.4 years) were c...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Am J Transl Res
Главные авторы: Sung, Pei-Hsun, Lin, Hung-Sheng, Lin, Wei-Che, Chang, Chiung-Chih, Pei, Sung-Nan, Ma, Ming-Chun, Chen, Kuan-Hung, Chiang, John Y, Chang, Hsueh-Wen, Lee, Fan-Yen, Lee, Mel S, Yip, Hon-Kan
Формат: Artigo
Язык:Inglês
Опубликовано: e-Century Publishing Corporation 2018
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6176223/
https://ncbi.nlm.nih.gov/pubmed/30323884
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы